Wikidata

(Q54342085)

English

Phase II trial of cetuximab plus irinotecan for oxaliplatin- and irinotecan-based chemotherapy-refractory patients with advanced and/or metastatic colorectal cancer: evaluation of efficacy and safety based on KRAS mutation status (T-CORE0801).

scientific article

In more languages

Statements

title
Phase II trial of cetuximab plus irinotecan for oxaliplatin- and irinotecan-based chemotherapy-refractory patients with advanced and/or metastatic colorectal cancer: evaluation of efficacy and safety based on KRAS mutation status (T-CORE0801) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24968756
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24968756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54342085&oldid=1566605109"